Literature DB >> 2174901

Comparative evaluation of two test methods (enzyme immunoassay and latex fixation) for the detection of heterophil antibodies in infectious mononucleosis.

M Kim1, M Wadke.   

Abstract

The present study evaluated the Ventrescreen Mono enzyme immunoassay (Ventrex Laboratories) and Monolatex (Wampole Laboratories) for detection of infectious mononucleosis-specific heterophil antibodies by comparing test results on sera of 247 symptomatic patients. The purpose of this study was to compare not only the two different test systems but also the two different methods they represent for accuracy in detecting infectious mononucleosis-specific heterophil antibodies. Discrepancies in the test results of the two kits were arbitrated by determining the Epstein-Barr virus antibody profiles of the samples. The study showed that the Ventrescreen Mono enzyme immunoassay is as good as the Monolatex test for detecting heterophil antibodies. After discrepancies were resolved, the sensitivity and specificity of the Ventrescreen assay were 100 and 98%, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174901      PMCID: PMC268216          DOI: 10.1128/jcm.28.11.2511-2513.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Evaluation of latex-based heterophile antibody assay for diagnosis of acute infectious mononucleosis.

Authors:  L Cook; J Midgett; D Willis; B Clinton; J D Folds
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

2.  Serological testing for Epstein-Barr virus--developments in interpretation.

Authors:  C V Sumaya
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

3.  The history of infectious mononucleosis.

Authors:  A S Evans
Journal:  Am J Med Sci       Date:  1974-03       Impact factor: 2.378

Review 4.  Selected aspects of acute and chronic infectious mononucleosis and mononucleosis-like illnesses for the practicing allergist.

Authors:  T A Steeper; C A Horwitz; W Henle; G Henle
Journal:  Ann Allergy       Date:  1987-10

5.  EBV-IgA and new heterophile antibody tests in diagnosis of infectious mononucleosis.

Authors:  A S Evans; J C Niederman
Journal:  Am J Clin Pathol       Date:  1982-05       Impact factor: 2.493

6.  Comparative evaluation of three commercial tests for detection of heterophile antibody in patients with infectious mononucleosis.

Authors:  R C Tilton; F Dias; R W Ryan
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

  6 in total
  5 in total

1.  Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska.

Authors:  Anthony R Sambol; Steven H Hinrichs; Wayne R Hogrefe; Beth K Schweitzer
Journal:  Clin Vaccine Immunol       Date:  2006-11-22

2.  Evaluation of a new commercial enzyme immunoassay for the detection of IgM antibodies to West Nile virus using a ratio method to eliminate nonspecific reactivity.

Authors:  Ryan J Welch; Brian L Anderson; Christine M Litwin
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

3.  Rapid detection of infectious mononucleosis-associated heterophile antibodies by a novel immunochromatographic assay and a latex agglutination test.

Authors:  S E Farhat; S Finn; R Chua; B Smith; A E Simor; P George; B B Diena; D Diena; M Skulnick
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

4.  Evaluation of an enzyme immunoassay for detection of immunoglobulin M antibodies to West Nile virus and the importance of background subtraction in detecting nonspecific reactivity.

Authors:  Mindy L Rawlins; Erica M Swenson; Harry R Hill; Christine M Litwin
Journal:  Clin Vaccine Immunol       Date:  2007-04-11

5.  Comparison of serological and molecular test for diagnosis of infectious mononucleosis.

Authors:  Hassan Salehi; Marziyeh Salehi; Rasoul Roghanian; Majid Bozari; Shirin Taleifard; Mohamad Mahdi Salehi; Maryam Salehi
Journal:  Adv Biomed Res       Date:  2016-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.